Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells

Cell Growth and Differentiation

Volumn 7, Issue 1, 1996, Pages 65-74

  Wilcken, Nicholas R C ^a   Sarcevic, Boris ^a   Musgrove, Elizabeth A ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ALITRETINOIN; ANTIESTROGEN; CYCLIN DEPENDENT KINASE; FULVESTRANT; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RETINOIC ACID; RETINOID;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS; PHOSPHORYLATION; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS C-MYC; RETINOIDS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030046296     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Kraemer, K. H., DiGiovanna, J. J., Moshell, A. N., Tarone, R., and Peck, G. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med., 378: 1633-1637, 1988.
2. Hong, W. K., Lippman, S. M., Itn, L. M., Karp, D., Byers, R., Schantz, S., Kramer, A., Lotan, R., Peters, L., Dimery, I., Brown, B., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990
3. Lippman, S M , Batsakis, J. G., Toth, B. B., Weber, R S., Lee, J , Martin, J., Hays, G., Goepfert, H., and Hong, W. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Eng. J Med., 328: 15-20, 1993.
4. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rosmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P., and Ravasi, G. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J Clin. Oncol., 11: 1216-1222, 1993.
5. Meyskens, F. L., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, T., Johnson, C. S., and Alberts, D. S Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid. J. Natl. Cancer Inst., 86: 539-543, 1994.
6. Lippman, S. M., Kavanagh, J. J., Paredes, E. M., Delgadillo, M. F , Paredes, C. P., Hong, W. K., Holdener, E., and Krakoff, I. H. 13-cis-Retinoic acid plus interferon alpha-2a. highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 84: 241-245, 1992.
7. Lippman, S. M., Parkinson, D. R., Itn, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., and Hong, W. K. 13-cis-Retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst., 84: 235-241, 1992.
8. Moon, R. C , Mehta, R G., and Detrisac, C. J. Retinoids as chemopreventive agents for breast cancer. Cancer Detect. Prev., 16: 73-79, 1992.
9. Teelmann, K., and Bollag, W Therapeutic effects of the arotinoid Ro 15-0778 on chemically induced rat mammary carcinoma. Eur. J. Cancer. Clin. Oncol., 24: 1205-1209, 1988.
10. Lacroix, A., Doskas, C., and Bhat, P. V. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovanectomy. Cancer Res., 50: 5731-5734, 1990.
11. Teelmann, K., Tsukagucni, T., Kluas, M., and Eliason, J. F. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans-and 13-cis-retinoic acid on rat breast cancer. Cancer Res., 53: 2319-2325, 1993.
12. McBurney, M. W., Costa, S., and Pratt, M. A. C. Retinoids and cancer: a basis for differentiation therapy. Cancer. Invest., 11: 590-598, 1993.
13. Bacus, S. S., Kiguchi, K., Chin, D., King, C. R., and Huberman, E Differentiation of cultured human breast cancer cells (Au-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol. Carcinog., 3: 350-362, 1990.
14. Guilbaud, N. F., Gas, N., Dupont, M. A , and Valette, A. Effects of differentiation-inducing agents on maturing of human MCF-7 breast cancer cells. J. Cell Physiol., 145: 162-172, 1990.
15. Gardner, F. J. E., and Walker, R. A. Modulation of cell surface components of human breast cancer cells by retinoic acid: enhanced HLA-DR expression. J. Pathol., 170: 23-29, 1993.
16. Fontana, J A. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell. Biol., 55: 136-144, 1987.
17. Marth, C., Bock, G., and Daxenbichler, G. Effect of 4-hydroxyphenyl-retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst., 75: 871-875, 1985.
18. Preisler, H. D., Gopal, V., Banavali, S. D., Finke, D., and Bokari, S. A. J. Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents. Cancer Res., 52: 4090-4095, 1992.
19. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res., 52: 2236-2242, 1992.
20. Koga, M., and Sutherland, R. L. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antiestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem Mol. Biol., 39: 455-460, 1991.
21. van der Burg, B., van der Leeds, B-J. M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1992.
22. Anzano, M. A., Byers, S. W., Smith, J. M , Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B., and Sporn, M. B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res., 54: 4614-4617, 1994.
23. 1 cyclins. Cell, 73: 1059-1065, 1993.
24. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
25. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
26. Akiyama, T., Ohuchi, T., Sumida, S., Matsumoto, K., and Toyoshima, K. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA, 89: 7900-7904, 1992.
27. Kato, J-y., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Dev., 7, 331-342, 1993.
28. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev., 8: 9-22, 1994.
29. Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., and Sutherland, R. L. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13: 3577-3587, 1993.
30. 1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA, 91: 8022-8026, 1994.
31. Musgrove, E. A., Sarcevic, B., and Sutherland, R. L. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for CDK2 activation and pRB hyperphosphorytation. J. Cell Biochem., in press, 1995.
32. Watson, P. H., Pon, R. T., and Shiu, R. P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical rote for c-myc in the growth of human breast cancer. Cancer Res., 51: 3996-4000, 1991.
33. Musgrove, E. A., Wakeling, A. E., and Sutherland, R. L Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res., 49: 2398-2404, 1989.
34. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. E., and Thaller, C. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992.
35. Crettaz, M., Baron, A., Siegenthaler, G., and Hunziker, W. Ligand specificities of recombinant retinoic acid receptors RAR α and RAR β. Biochem J., 272: 391-397, 1990.
36. Clarke, C. L., Roman, S. D., Graham, J., Koga, M., and Sutherland, R. L. Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. J. Biol. Chem., 265: 12694-12700, 1990.
37. Sporn, M. B., and Roberts, A B. Interactions of retinoids and transforming growth factor-β in regulation of cell differentiation and proliferation. Mol. Endocrinol., 5: 3-7, 1991.
38. Zhou, H., Manji, S. S., Findlay, D. M , Martin, T. J , Heath, J. K , and Ng, K. W. Novel action of retinoic acid: stabilization of newly synthesized alkaline phosphatase transcripts. J Biol. Chem., 269: 22433-22439, 1994.
39. 1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol., 19: 615-621, 1983.
40. Hall, R E., Tilley, W. D., McPhaul, M. J., and Sutherland, R. L. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells. Int. J. Cancer, 52: 778-784, 1992.
41. Demirpence, E., Pons, M., Balaguer, P., and Gagne, D. Study of an antiestrogenic effect of retinoic acid in MCF-7 cells. Biochem. Biophys. Res. Commun., 183: 100-106, 1992.
42. Demirpence, E., Balaguer, P., Trousse, F., Nicolas, J-C., Pons, M., and Gagne, D. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res., 54 1458-1464, 1994.
43. Musgrove, E. A., Hamilton, J. A., Lee, C. S. L., Sweeney, K. J. E., Watts, C. K. W., and Sutherland, R. L. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13: 3577-3587, 1993.
44. Watts, C. K. W., Sweeney, K. J. E., Warlters, A , Musgrove, E. A., and Sutherland, R. L. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res. Treat., 31: 95-105, 1994.
45. Cocks, B. G., Viaro, G., Bodrug, S, E., and Hamilton, J. A. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem., 267: 12307-12310, 1992.
46. Dony, C., Kessel, M., and Gruss, P. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9 Nature (Lond.), 317: 636-638, 1985.
47. Bentley, D. L., and Groudine, M A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (Lond.), 321: 702-706, 1986.
48. Somay, C., Grunt, T. W., Mannhalter, C., and Dittrich, C. Relationship of myc protein to the phenotype and to the growth potential of HOC-7 ovarian cancer cells. Br. J. Cancer, 66: 93-98, 1992.
49. Stopera, S. A., and Bird, R. P. Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci, differential expression of c-myc and c-fos mRNA and protein Int. J. Cancer, 53: 798-804, 1993.
50. Kalemkerian, G. P., Jasti, R. K., Celano, P., Nelkin, B. D., and Mabry, M. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth & Differ., 5: 55-60, 1994
51. Saunders, D. E., Christensen, C., Wapple, N. L., Schultz, J. F., Lawrence, W. D., Malviya, V. K., Malone, J. M., and Deppe, G. Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anti-Cancer Drugs, 4: 201-208, 1993.
52. Sheikh, M. S., Shao, Z., Chen, J., Ordonez, J. V., and Fontana, J. A. Retinoid modulation of c-myc and max gene expression in human breast carcinoma. Anticancer Res., 13: 1387-1392, 1993.
53. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J , Verma, I. M., and Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA, 88: 6092-6096, 1991.
54. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell, 71: 323-334, 1992.
55. Watts, C. K. W., Brady, A., Sarcevic, B., deFazio, A., Musgrove, E. A., and Sutherland, R. L Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol., 9. 1804-1813, 1995.
56. Matsushime, H., Roussel, M. F., Ashmun, R. A., and Sherr, C. J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65: 701-713, 1991.
57. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., and Roberts, J. M Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1694, 1992.
58. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
59. Hinds, P. W., Mittnacht, S., Dulic, V , Arnold, A., Reed, S. I., and Weinberg, R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
60. Dowdy, S F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73: 499-511, 1993.
61. Hannon, G. J., and Beach, D p15INK4B is a potent effector of TGFβ-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994
62. Kato, J., Matsuoka, M., Polyak, K., Massagué, J., and Sherr, C Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
63. Fanjul, F., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.) 372: 107-111, 1994.
64. Adamo, M. L., Shao, Z. M., Lanau, F., Chen, J. C., Clemmons, D. R., Roberts, C. T., LeRoith, D., and Fontana, J. A. Insulin-like growth factor-1 (IGF-1) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3 and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology, 131: 1858-1866, 1992.
65. Martin, J. L., Coverley, J. A., Pattison, S. T., and Baxter, R C. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology, 136: 1219-1226, 1995.
66. Musgrove, E. A., Lee, C. S. L., and Sutherland, R. L. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos and c-myc genes. Mol. Cell. Biol., 11: 5032-5043, 1991.
67. Xiong, Y., Connolly, T., Futcher, B., and Beach, D Human D-type cyclin. Cell, 65: 691-699, 1991.
68. Lew, D. J., Dulic, V., and Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell, 66: 1197-1206, 1991.
69. Pines, J., and Hunter, T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (Lond.), 346: 760-763, 1990.
70. Hanks, S. K Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl. Acad. Sci. USA, 84: 388-392, 1987.
71. Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., and Livingston, D. M. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell, 64: 521-532, 1991